Adults 12 to 60, any sex, with Orthodontic Treatment or Tooth Crowding. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Litter's Index (Change in Little's Index Mean Total Score From Baseline)Primary· Movement was recorded by capturing the start and end point of the 6 anterior teeth before and at the completion of the treatment respectively. Changes was compared and assessed. The duration of the treatment was an average of 10 months.
The Litter's Index of Displacement score is the primary clinical endpoint used to judge patient success. Tooth alignment is assessed by Litter's Index of Displacement. It is performed at the five contact points for the teeth located in lower 1's through 3's. This index is the sum of the numbers recorded at each of the 5 points which are in millimeters.
Subjects were followed for a total of up to 15 months or until achieving a Little's index of \<1.5, whichever came first. The Litter's Index was performed at the baseline and the end-point of the study.
Data was analyzed by comparing the Basel
Baseline Little's Index
Group
Value
95% CI
Aerodentis System
5.7
± 2.3
Invisalign Clear Aligner System
6.2
± 2.9
Endpoint Little's Index
Group
Value
95% CI
Aerodentis System
0.6
± 0.5
Invisalign Clear Aligner System
0.3
± 0.3
Change of Little's Index
Group
Value
95% CI
Aerodentis System
-3.9
± 2.8
Invisalign Clear Aligner System
-4.7
± 2.8
Sponsor's own description
The purpose of this study is to evaluate the efficacy of the Aerodentis System for orthodontic tooth movement in an open label, two-arms, non-inferiority clinical study. This open-label, two-arm study will follow 45 patients for up to fifteen months. Thirty participants will wear the Aerodentis device, and fifteen participants will wear Invisalign, a commonly used clear appliance. Patients will be assigned to participate in the treatment group using the Aerodentis device at home for 10 hours daily or in the control group using clear correctors for the duration of up to 15 months. Outcome assessments will be performed every 4 weeks. Assessments will include tooth movement and quality of life assessments.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT07091422 — A Split-Mouth Clinical Trial Evaluating the Bond Failure Rate of a New Etch-Free Orthodontic Adhesive
· NA
· recruiting
NCT06948162 — Exploration of the Utility of Dental-dedicated MRI for Dentistry
· recruiting
NCT06858670 — Effectiveness of Auxiliary Segmental Lingual Appliances in Leveling the Curve of Wilson at Second Molars
· NA
· recruiting
NCT07107100 — Comparison of Periodontal Health, Bonding Time and Failure Between Direct and Indirect Fixed Retainer Placement Among Or
· NA
· recruiting
NCT07445555 — Gingival Recessions in Orthodontically Treated and Untreated Adult Patients
· recruiting
Other University of Alabama at Birmingham trials
Trials by the same sponsor.
NCT04922229 — Comparative Effectiveness in the Management of Irreversible Pulpitis
· NA
· not yet recruiting
NCT05060380 — Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis
· NA
· withdrawn
NCT04768777 — Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis
· NA
· not yet recruiting
NCT06320951 — VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine
· Phase 2
· not yet recruiting
NCT07564934 — Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children With Disabilit
· Phase 2
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Alabama at Birmingham
Last refreshed: 4 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03421886.